Lv31
380 积分 2024-01-15 加入
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents
4小时前
待确认
Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review
5小时前
已完结
Perioperative Therapy for Resectable Non–Small-Cell Lung Cancer: Weighing Options for the Present and Future
5小时前
已完结
Top advances of the year: Perioperative therapy for lung cancer
5小时前
已完结
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer
4天前
已完结
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma
6天前
已完结
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
6天前
已完结
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
8天前
已完结
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
8天前
已完结
The efficacy and safety of neoadjuvant immunochemotherapy in resectable stage I-III non-small cell lung cancer: a systematic review and network meta-analysis
8天前
已完结
皖公网安备34019202002308
